{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:28Z","timestamp":1791919528878,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"am","delay-in-days":242,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pnpbp.2024.111108","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:27:29Z","timestamp":1722036449000},"page":"111108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response"],"prefix":"10.1016","volume":"135","author":[{"given":"Sharon","family":"Miksys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Baghai Wadji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F.","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111108_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0091-3057(95)00131-F","article-title":"Hypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism","volume":"52","author":"Abdel-Fattah","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0010","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1007\/s12035-021-02560-1","article-title":"Sex and estrous cycle differences in analgesia and brain oxycodone levels","volume":"58","author":"Arguelles","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114949","article-title":"Sex, estrous cycle, and hormone regulation of CYP2D in the brain alters oxycodone metabolism and analgesia","volume":"198","author":"Arguelles","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0020","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0006-2952(94)90327-1","article-title":"An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype","volume":"47","author":"Barham","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0025","first-page":"31","article-title":"Anatomical distribution of NADPH-cytochrome P450 reductase and cytochrome P4502D forms in rat brain: effects of xenobiotics and sex steroids","volume":"162","author":"Bergh","year":"1996","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1523\/JNEUROSCI.02-02-00199.1982","article-title":"Modulation by estradiol of serotonin receptors in brain","volume":"2","author":"Biegon","year":"1982","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(80)90509-0","article-title":"Serotonin receptor concentration during the estrous cycle of the rat","volume":"187","author":"Biegon","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0040","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2011.07339.x","article-title":"Cytochrome P450 mediates dopamine formation in the brain in vivo","volume":"118","author":"Bromek","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/00498254.2013.791410","article-title":"Potential role of CYP2D6 in the central nervous system","volume":"43","author":"Cheng","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0050","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bcp.2010.12.019","article-title":"Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats","volume":"81","author":"Choi","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/dmd.112.046276","article-title":"Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone","volume":"41","author":"Choi","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623315570339","article-title":"Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears","volume":"43","author":"Cora","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/109158101317097746","article-title":"Gender-based differences in pharmacokinetics in laboratory animal models","volume":"20","author":"Czerniak","year":"2001","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1096-4959(02)00119-7","article-title":"Estrous cycle-regulated expression of CYP1B1 mRNA in the rat ovary","volume":"133","author":"Dasmahapatra","year":"2002","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0075","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.bcp.2008.01.012","article-title":"Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy","volume":"75","author":"Dickmann","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0080","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/npp.2015.40","article-title":"Effect of brain CYP2B inhibition on brain nicotine levels and nicotine self-administration","volume":"40","author":"Garcia","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/dmd.122.000915","article-title":"Sexual dimorphism in the expression of cytochrome P450 enzymes in rat heart, liver, kidney, lung, brain, and small intestine","volume":"51","author":"Gerges","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0090","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/FTD.0b013e31817d6f5d","article-title":"CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response","volume":"30","author":"Gex-Fabry","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/bdrb.20106","article-title":"The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies","volume":"80","author":"Goldman","year":"2007","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00228-004-0766-8","article-title":"Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting","volume":"60","author":"Grasmader","year":"2004","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2021.12.001","article-title":"Roles of cytochrome P450 enzymes in pharmacology and toxicology: past, present, and future","volume":"95","author":"Guengerich","year":"2022","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jnc.13031","article-title":"The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study","volume":"133","author":"Haduch","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1570-0232(02)01042-5","article-title":"Determination of dextromethorphan and its metabolites in rat serum by liquid-liquid extraction and liquid chromatography with fluorescence detection","volume":"788","author":"Hendrickson","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuropharm.2014.10.013","article-title":"Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors","volume":"89","author":"Jiang","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00737-020-01094-0","article-title":"Addictive behaviors across the menstrual cycle: a systematic review","volume":"24","author":"Joyce","year":"2021","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/npp.2010.202","article-title":"Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects","volume":"36","author":"Khokhar","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/toxsci\/kfs029","article-title":"Rat brain CYP2B-enzymatic activation of chlorpyrifos to the oxon mediates cholinergic neurotoxicity","volume":"126","author":"Khokhar","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/abbi.1996.9771","article-title":"Inhibition of monoamine oxidase a by beta-carboline derivatives","volume":"337","author":"Kim","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"issue":"237","key":"10.1016\/j.pnpbp.2024.111108_bb0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/mp.2010.42","article-title":"CYP2D6 in the brain: genotype effects on resting brain perfusion","volume":"16","author":"Kirchheiner","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/JOE-19-0561","article-title":"Sex steroid hormones differentially regulate CYP2D in female wild-type and CYP2D6-humanized mice","volume":"245","author":"Konstandi","year":"2020","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00204-011-0730-1","article-title":"Expression of hepatic and ovarian cytochrome P450 during estrous cycle in rats","volume":"86","author":"Lee","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(76)90358-7","article-title":"Disposition of propranolol isomers in mice","volume":"40","author":"Levy","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-002-1183-2","article-title":"Biological basis of sex differences in drug abuse: preclinical and clinical studies","volume":"164","author":"Lynch","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neuropharm.2008.07.017","article-title":"Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment","volume":"55","author":"Mann","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0006-8993(99)01439-0","article-title":"Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors","volume":"831","author":"Maswood","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/00912700122010627","article-title":"Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan","volume":"41","author":"McCune","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pharmthera.2017.10.008","article-title":"CYP-mediated drug metabolism in the brain impacts drug response","volume":"184","author":"McMillan","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/adb.12590","article-title":"Rat brain CYP2D activity alters in vivo central oxycodone metabolism, levels and resulting analgesia","volume":"24","author":"McMillan","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0195","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.brainresbull.2020.09.001","article-title":"Centrally administered CYP2D inhibitors increase oral tramadol analgesia in rats","volume":"164","author":"McMillan","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0200","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1471-4159.2002.01069.x","article-title":"Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics","volume":"82","author":"Miksys","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2017.04.030","article-title":"Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms","volume":"78","author":"Miksys","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0210","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1111\/bph.12652","article-title":"Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys","volume":"171","author":"Miller","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-5198(19)43558-0","article-title":"Estimation of harmine and its derivatives by HPLC: correlation of brain harmine levels with jumping behavior in rats","volume":"43","author":"Moroi","year":"1987","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinformatics."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.541","article-title":"Individualized medicine: sex, hormones, genetics, and adverse drug reactions","volume":"7","author":"Moyer","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0230","first-page":"334","article-title":"Higher gene expression of CYP1A2, 2B1 and 2D2 in the brain of female compared with male rats","volume":"71","author":"Nagai","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bcp.12227","article-title":"CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials","volume":"77","author":"Penas-Lledo","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109291","article-title":"CYP2D in the brain impacts oral hydrocodone analgesia in vivo","volume":"221","author":"Richards","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0245","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/0006-2952(87)90592-2","article-title":"Irreversible binding and metabolism of propranolol by human liver microsomes--relationship to polymorphic oxidation","volume":"36","author":"Shaw","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002280050220","article-title":"Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study","volume":"51","author":"Spina","year":"1997","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0255","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1124\/dmd.105.005124","article-title":"Estrous cycle alters naphthalene metabolism in female mouse airways","volume":"33","author":"Stelck","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.apha.2022.04.003","article-title":"Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain","volume":"95","author":"Stocco","year":"2022","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0265","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1007\/s12035-020-02050-w","article-title":"Human CYP2D6 in the brain is protective against Harmine-induced neurotoxicity: evidence from humanized CYP2D6 transgenic mice","volume":"57","author":"Stocco","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0270","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00213-021-05808-9","article-title":"The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization","volume":"238","author":"Stocco","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/genes11111295","article-title":"A review of the important role of CYP2D6 in pharmacogenomics","volume":"11","author":"Taylor","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2005.12.007","article-title":"Menstrual cycle phase and responses to drugs of abuse in humans","volume":"84","author":"Terner","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0285","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s12035-020-01896-4","article-title":"Human CYP2D6 is functional in brain in vivo: evidence from humanized CYP2D6 transgenic mice","volume":"57","author":"Tolledo","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0290","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/pharmrev.121.000361","article-title":"Sex\/gender differences in the time-course for the development of substance use disorder: a focus on the telescoping effect","volume":"75","author":"Towers","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0295","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2013.12.025","article-title":"The endogenous substrates of brain CYP2D","volume":"724","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0305","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1073\/pnas.91.3.1019","article-title":"Effect of ethanol on cytochrome P450 in the rat brain","volume":"91","author":"Warner","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.111108_bb0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0315","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1124\/jpet.104.068908","article-title":"Estrogen regulation of the cytochrome P450 3A subfamily in humans","volume":"311","author":"Williams","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0320","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.102.047050","article-title":"Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine","volume":"305","author":"Yu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0325","first-page":"54","article-title":"Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course","volume":"33","author":"Yue","year":"2008","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2024.111108_bb0335","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.bcp.2013.04.014","article-title":"First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo","volume":"85","author":"Zhou","year":"2013","journal-title":"Biochem. Pharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T22:50:05Z","timestamp":1728514205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":67,"alternative-id":["S0278584624001763"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111108","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human CYP2D6 varies across the estrous cycle in brains of transgenic mice altering drug response","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111108"}}